Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-18

Clinical Trial Update: Study of Behavioral Modification Program and Mirabegron to Improve Urinary Urgency in Multiple Sclerosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating a behavioral modification program in combination with mirabegron to improve urinary urgency in people with multiple sclerosis;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mirabegron (mirabegron)

Snippet

Sponsor: Theodore R. Brown, MD MPH | Conditions: Multiple Sclerosis | Phase 4 | Status: COMPLETED | Results posted: 2023-10-18